{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:12:21Z","timestamp":1792239141256,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajog.2024.06.051","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:18:40Z","timestamp":1722428320000},"page":"110.e1-110.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and molecular risk factors for repeat interventions due to symptomatic uterine leiomyomas"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6868-2341","authenticated-orcid":false,"given":"Sara","family":"Khamaiseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u00c4yr\u00e4v\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maare","family":"Arffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siiri","family":"Reinikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miika","family":"Mehine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"H\u00e4rkki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"B\u00fctzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka","family":"Pasanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Vahteristo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.06.051_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.06.051_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rbmo.2020.01.003","article-title":"Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids","volume":"40","author":"Khaw","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2024.06.051_bib3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1089\/jwh.2017.6752","article-title":"Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids","volume":"27","author":"Davis","year":"2018","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.ajog.2024.06.051_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jog.13519","article-title":"Recurrence of uterine myoma after myomectomy: open myomectomy versus laparoscopic myomectomy","volume":"44","author":"Kotani","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2024.06.051_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.fertnstert.2017.11.033","article-title":"Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis","volume":"109","author":"Sandberg","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.06.051_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejogrb.2014.05.029","article-title":"Long-term risk of fibroid recurrence after laparoscopic myomectomy","volume":"180","author":"Radosa","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.06.051_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254142","article-title":"A\u00a0prognostic index model for predicting long-term recurrence of uterine leiomyoma after myomectomy","volume":"16","author":"Ming","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2024.06.051_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jmig.2016.01.017","article-title":"Nonmalignant sequelae of unconfined morcellation at laparoscopic hysterectomy or myomectomy","volume":"23","author":"Tulandi","year":"2016","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2024.06.051_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","article-title":"Genomics of uterine leiomyomas: insights from high-throughput sequencing","volume":"102","author":"Mehine","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.06.051_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajog.2024.06.051_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase\u2013deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2024.06.051_bib12","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2024.06.051_bib13","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/humrep\/deaa187","article-title":"Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy","volume":"35","author":"\u00c4yr\u00e4v\u00e4inen","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.06.051_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03747-1","article-title":"Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma","volume":"596","author":"Berta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2024.06.051_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41389-022-00425-3","article-title":"A\u00a0novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase","volume":"11","author":"Mehine","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ajog.2024.06.051_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/molehr\/gat083","article-title":"Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues","volume":"20","author":"Holdsworth-Carson","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ajog.2024.06.051_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2024.06.051_bib18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ajog.2005.02.097","article-title":"Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis","volume":"193","author":"Canevari","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.051_bib19","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.humpath.2006.05.005","article-title":"Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma","volume":"37","author":"Zhang","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2024.06.051_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.06.051_bib21","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1093\/hmg\/ddv177","article-title":"Clonally related uterine leiomyomas are common and display branched tumor evolution","volume":"24","author":"Mehine","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajog.2024.06.051_bib22","series-title":"Genomics in the cloud: Using Docker, GATK, and WDL in Terra","author":"Van der Auwera","year":"2020"},{"key":"10.1016\/j.ajog.2024.06.051_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A\u00a0global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2024.06.051_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A\u00a0genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2024.06.051_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ajog.2024.06.051_bib26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2024.06.051_bib27","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2024.06.051_bib28","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/aogs.14248","article-title":"Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology","volume":"100","author":"Uimari","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2024.06.051_bib29","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer Genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.ajog.2024.06.051_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2015.08.034","article-title":"The incidence of hysterectomy, uterus-preserving procedures and recurrent treatment in the management of uterine fibroids","volume":"194","author":"Mart\u00edn-Merino","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.06.051_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jmig.2007.06.003","article-title":"Predictors of leiomyoma recurrence after laparoscopic myomectomy","volume":"14","author":"Yoo","year":"2007","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2024.06.051_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25806-x","article-title":"Parity associates with chromosomal damage in uterine leiomyomas","volume":"12","author":"Kuisma","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2024.06.051_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejogrb.2009.03.009","article-title":"Laparoscopic versus open myomectomy-A meta-analysis of randomized controlled trials","volume":"145","author":"Jin","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.06.051_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89859-0","article-title":"Alterations in lipid profile upon uterine fibroids and its recurrence","volume":"11","author":"Tonoyan","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2024.06.051_bib35","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e2671","article-title":"Long non-coding ribonucleic acid H19 and ten-eleven translocation enzyme 1 messenger RNA expression levels in uterine fibroids may predict their postoperative recurrence","volume":"76","author":"Zhan","year":"2021","journal-title":"Clinics"},{"key":"10.1016\/j.ajog.2024.06.051_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2024.06.051_bib37","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archdermatol.2008.517","article-title":"Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer","volume":"144","author":"Stewart","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ajog.2024.06.051_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ajhg.2023.01.009","article-title":"Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas","volume":"110","author":"V\u00e4lim\u00e4ki","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2024.06.051_bib39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/1471-0528.17412","article-title":"Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: a retrospective cohort study of long-term outcomes","volume":"130","author":"Amoah","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2024.06.051_bib40","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1038\/s41467-018-05428-6","article-title":"Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits","volume":"9","author":"Rafnar","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2024.06.051_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37110","article-title":"Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability","volume":"7","author":"V\u00e4lim\u00e4ki","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ajog.2024.06.051_bib42","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/s41467-019-12536-4","article-title":"Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis","volume":"10","author":"Gallagher","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2024.06.051_bib43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-023-35974-7","article-title":"Evidence of a causal effect of genetic tendency to gain muscle mass on uterine leiomyomata","volume":"14","author":"Sliz","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2024.06.051_bib44","first-page":"410","article-title":"A\u00a0novel nonsense mutation in the fumarate hydratase gene in a Chinese patient with recurrent leiomyomas","volume":"4","author":"Ruan","year":"2023","journal-title":"F\u00a0S Rep"},{"key":"10.1016\/j.ajog.2024.06.051_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2024.06.051_bib46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/PAS.0000000000001826","article-title":"Comparison of 2SC, AKR1B10, and FH antibodies as potential biomarkers for FH-deficient uterine leiomyomas","volume":"46","author":"Ahvenainen","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2024.06.051_bib47","series-title":"Genomics in the cloud: using Docker, GATK, and WDL in Terra","author":"Van der Auwera","year":"2020"},{"key":"10.1016\/j.ajog.2024.06.051_bib48","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows\u2013Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajog.2024.06.051_bib49","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajog.2024.06.051_bib50","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1038\/s41596-018-0052-3","article-title":"Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer","volume":"13","author":"Katainen","year":"2018","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajog.2024.06.051_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A\u00a0global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2024.06.051_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A\u00a0genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2024.06.051_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ajog.2024.06.051_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824008093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824008093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T14:09:33Z","timestamp":1735049373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824008093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0002937824008093"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.06.051","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular risk factors for repeat interventions due to symptomatic uterine leiomyomas","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}